This reactive astrocyte phenotype is also observed in active MS lesions, reflected by co‐expression of C3 and GFAP, and to a lesser extent also in chronic active and inactive lesions (Liddelow et al., 2017), suggesting this phenotype is mostly present during earlier phases of lesion pathology. The gene discussed is C3; the disease is myeloid sarcoma.